This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It
includes advice on diagnosis, education and support, blood glucose management, cardiovascular
risk, and identifying and managing long-term complications....
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes....
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Blood Glucose,
Combined Modality Therapy,
Diabetes Mellitus, Type 1,
Diabetes Mellitus, Type 2,
Diet, Diabetic,
Drug Monitoring,
Endocrinology,
Hyperglycemia,
Hypoglycemia,
Insulin/therapeutic use,
Insulin Infusion Systems,
Monitoring, Ambulatory,
Patient Education as Topic,
Precision Medicine,
Diabetes Mellitus, Type 1/drug therapy,
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 1/therapy,
Diabetes Mellitus, Type 2/therapy,
Hypoglycemic Agents/therapeutic use,
Hypoglycemic Agents/adverse effects,
Insulin/adverse effects
El objetivo general de esta GPC es proporcionar orientación sobre las diversas alternativas de los cuidados que se proporcionan a las personas con DM1, estableciendo recomendaciones basadas en la evidencia mas relevante y actual. También se pretende desarrollar estándares que puedan maximizar la calid...
Diabetes Mellitus, Type 1/complications,
Diabetes Mellitus, Type 1/diagnosis,
Diabetes Mellitus, Type 1/drug therapy,
Insulin, Regular, Human/therapeutic use,
Insulin Glargine/therapeutic use,
Insulin Detemir/therapeutic use,
Diabetic Foot/prevention & control,
Diabetic Neuropathies/prevention & control,
Risk Factors,
Critical Pathways/organization & administration
